Monash University has established a ground breaking partnership with Breakthrough Victoria aimed at bolstering its already impressive track record in nurturing spinout ventures with a dedicated allocation of $15 million in pre-seed investment.
This innovative initiative is poised to serve as a catalyst, providing crucial early-stage capital and guidance to propel the growth of spinout ventures originating from the university.
Professor Doron Ben-Meir, Deputy Vice Chancellor Enterprise and Engagement at Monash University, expressed his enthusiasm and vision for this co-investment partnership.
"In addition to reaffirming Monash's unwavering commitment to fostering innovation, this collaboration builds on our foundations for an increasingly robust pipeline of future spinout enterprises, further amplifying our university's ability to create a lasting and positive societal impact.
"This initiative will support early-stage spinout innovation, serving the dual purpose of enhancing product development and safeguarding research with strong commercial potential, ensuring its successful path to market viability," Professor Ben-Meir said.
The $15 million pre-seed support will enable investment of up to $500,000 into Monash innovation and development for new ventures spun out of Monash University research.
The partnership has been established under the $100 million Breakthrough Victoria – University Innovation Platform, which aims to increase commercialisation of critical research with industry and community benefits from Victorian universities.
Express your interest by letting us know about your proposed (or existing) venture through our expression of interest form.
About Monash Innovation
Monash Innovation drives commercialisation across the university, transforming bold ideas into impactful solutions that make the world a better place.
Over the past five years, the Commercialisation team has seamlessly guided the innovation journey of Monash's research, processing 561 invention disclosures, activating 213 patent families, completing 165 licence deals and spinning out 26 new ventures based on Monash IP.
Noteworthy spinouts – including Jupiter Ionics, Amaero International, Additive Assurance, Electralith, RAGE Biotech, Inosi and Aravax – have emerged where Monash holds equity and has invested directly to fund growth.
